About us Contacts Drug interactions: 390 212
Drug search by name

Aluminum Hydroxide and Magnesium Carbonate Chewable Tablets and Zemplar (Paricalcitol Capsules)

Determining the interaction of Aluminum Hydroxide and Magnesium Carbonate Chewable Tablets and Zemplar (Paricalcitol Capsules) and the possibility of their joint administration.

Check result:
Aluminum Hydroxide and Magnesium Carbonate Chewable Tablets <> Zemplar (Paricalcitol Capsules)
Relevance: 15.07.2022 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

Chronic use of aluminum hydroxide or other medications that contain aluminum may cause toxicity in patients with advanced kidney disease due to impaired ability to clear aluminum from the body. Aluminum can accumulate and deposit in various tissues over time, causing toxicities such as weak bones, fractures, bone pain, muscle weakness, anemia, mental changes, seizures, dementia, and coma. The risk of aluminum toxicity may be further increased during treatment with vitamin D or vitamin D analogs like paricalcitol, which increase the absorption of aluminum from the intestine. You should avoid taking medications that contain aluminum unless otherwise directed by your doctor. Always check the labels of over-the-counter medications to be sure they do not contain aluminum before you use them. Talk to your doctor or other healthcare professional if you are not sure whether a product contains aluminum. They may also be able to suggest alternative medications when necessary. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Professional:

GENERALLY AVOID: Chronic use of aluminum-containing preparations in patients with advanced renal impairment, particularly during treatment with vitamin D analogs, may result in increased blood levels of aluminum and aluminum toxicity. Patients with renal failure are at risk for toxicity due to impaired clearance of aluminum, and the risk may be further increased by the administration of vitamin D analogs due to increased intestinal absorption of aluminum. Toxicity may manifest as osteodystrophy, osteomalacia, myopathy, anemia, and encephalopathy.

MANAGEMENT: Aluminum-containing preparations (e.g., antacids, phosphate binders) should not be administered chronically with vitamin D analogs.

References
  • "Product Information. Zemplar (paricalcitol)." Abbott Pharmaceutical, Abbott Park, IL.
  • Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Aluminum Hydroxide and Magnesium Carbonate Chewable Tablets

Generic Name: aluminum hydroxide / magnesium carbonate

Brand name: Gaviscon Extra Relief Formula, Acid Gone, Gaviscon

Synonyms: n.a.

Zemplar (Paricalcitol Capsules)

Generic Name: paricalcitol

Brand name: Zemplar

Synonyms: Zemplar

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.